idarubicin [clinicaltrials_resource:8abda8ae8f9343df3ac38e7a4b258278]
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002517]Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia [clinicaltrials:NCT00002532]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00002549]Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission [clinicaltrials:NCT00002609]Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002658]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00002701]Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002719]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002761]Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002771]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002868]Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [clinicaltrials:NCT00002926]Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002989]Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00003268]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003602]Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003603]Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003639]Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia [clinicaltrials:NCT00003729]Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003758]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia [clinicaltrials:NCT00004905]Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00005823]Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00006122]Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [clinicaltrials:NCT00006232]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis [clinicaltrials:NCT00006367]Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00016159]Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00025402]Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome [clinicaltrials:NCT00077116]Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00107523]AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00180128]Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00199186]Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma [clinicaltrials:NCT00317408]Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia [clinicaltrials:NCT00458848]
intervention [clinicaltrials_vocabulary:intervention]
idarubicin [clinicaltrials_resource:8abda8ae8f9343df3ac38e7a4b258278]
Bio2RDF identifier
8abda8ae8f9343df3ac38e7a4b258278
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8abda8ae8f9343df3ac38e7a4b258278
intervention name [clinicaltrials_vocabulary:intervention-name]
idarubicin
identifier
clinicaltrials_resource:8abda8ae8f9343df3ac38e7a4b258278
title
idarubicin
@en
type
label
idarubicin [clinicaltrials_resource:8abda8ae8f9343df3ac38e7a4b258278]
@en